Cancer, Bladder Unknown Status Phase 2 Trials for Cisplatin (DB00515)

Also known as: Bladder Cancers / Bladder Cancer / Malignant neoplasm of urinary bladder NOS / Bladder neoplasms malignant / Malignant neoplasm of bladder / Urinary Bladder Cancer / Malignant neoplasm of bladder, part unspecified / Bladder cancer NOS / Ca bladder

IndicationStatusPhase
DBCOND0092003 (Cancer, Bladder)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00006111Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary TractTreatment
NCT00006118Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder CancerTreatment
NCT01222676Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the BladderTreatment